Breaking Down Barriers - A Casual Conversation with Roche

New information has just been published about further findings in the GENERATION-HD1 trial after being halted in 2021. We address some of these findings as well as dive into the GENERATION-HD2 trial with Dr. Peter McColgan from @roche during our next Breaking Down Barriers. This casual conversation was hosted by community members and HDYO Board Members, Dr. Lauren Byrne and Ashley Clarke.
To read the full article including comments from Drs. Sarah Tabrizi and Ed Wild, visit HDYO.ORG.
Breaking Down Barriers is sponsored by Teva Pharmaceutical, uniQure, The Griffin Foundation, Neurocrine Biosciences, Roche and Sage Therapeutics.
**Multiple languages will be offered on RUclips via closed captioning.